Holen Sie sich die Stockscreener-App
3.20
0.93%
-0.03
Handel nachbörslich:
3.18
-0.02
-0.63%
Finanzdaten der Cellectar Biosciences Inc-Aktie (CLRB)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
| Research and Development |
25.18%
3.1586
|
2.5233 | 2.3898 | 3.4271 | 6.2092 |
| Costs And Expenses |
17.32%
5.6906
|
4.8507 | 6.0375 | 6.401 | 12.74 |
| Operating Income/Loss |
17.32%
-5.6906
|
-4.8507 | -6.0375 | -6.401 | -12.74 |
| Nonoperating Income/Loss |
2.80%
0.3954
|
0.4068 | 0.5896 | -0.203 | 10.46 |
| Income/Loss From Continuing Operations Before Tax |
7.19%
-4.5018
|
-4.8507 | -5.4479 | -6.604 | -5.4826 |
| Income/Loss From Continuing Operations After Tax |
135.08%
1.5588
|
-4.4439 | -5.4479 | -6.604 | -2.3554 |
Net Income/Loss
|
19.16%
-5.2952
|
-4.4439 | -5.4479 | -6.604 | -2.3554 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
84.18%
0.5001
|
3.162 | 1.6088 | 46.08 | 1.772 |
| Diluted Average Shares |
84.18%
0.5001
|
3.162 | 1.6088 | 46.08 | 1.5983 |
| Basic Earnings Per Share |
62.41%
-0.53
|
-1.41 | -3.39 | -0.14 | -0.01 |
| Diluted Earnings Per Share |
62.41%
-0.53
|
-1.41 | -3.39 | -0.14 | -0.01 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):